IDEXX Laboratories (IDXX) Beats Q4 Earnings Estimates by $0.15

IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings results on February 02, 2026 that exceeded analyst expectations.

The Healthcare company reported earnings per share of $3.08, beating the consensus estimate of $2.93 by $0.15 per share. Revenue came in at $1.1B, beating the estimate of $1.1B.

IDEXX Laboratories's stock moved following the earnings release. The stock currently trades at $645.90 with a market capitalization of $56.5B.